シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 2,859,647株、対発行株数の割合は 3.75% です（2026-06-16公表時点、4機関が報告）。
空売り残高（合計）の推移
- Barclays Capital Securities
- GOLDMAN SACHS
- JPM Securities Japan Co
- Nomura
- UBS
- モルガン・スタンレーMUFG証券
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/03/17 | 8,491,255 | 12.37% (+0.61%) |
| 2026/03/16 | 8,055,626 | 11.76% (+5.51%) |
| 2026/03/13 | 4,302,621 | 6.25% (-0.07%) |
| 2026/03/12 | 4,347,591 | 6.32% (+0.42%) |
| 2026/03/11 | 4,053,080 | 5.90% (+0.41%) |
| 2026/03/10 | 3,767,723 | 5.49% (+0.34%) |
| 2026/03/09 | 3,536,835 | 5.15% (+0.17%) |
| 2026/03/06 | 3,407,807 | 4.98% (+0.63%) |
| 2026/03/05 | 2,966,882 | 4.35% (+0.14%) |
| 2026/03/04 | 2,874,782 | 4.21% (-1.08%) |
| 2026/03/03 | 3,624,339 | 5.29% (-1.69%) |
| 2026/03/02 | 4,771,432 | 6.98% (+0.32%) |
| 2026/02/27 | 4,552,898 | 6.66% (+0.96%) |
| 2026/02/26 | 3,888,798 | 5.70% (-0.32%) |
| 2026/02/25 | 4,103,367 | 6.02% (+0.93%) |
| 2026/02/24 | 3,424,413 | 5.09% (-3.69%) |
| 2026/02/20 | 5,477,732 | 8.33% (+0.35%) |
| 2026/02/19 | 5,161,795 | 7.98% (+0.77%) |
| 2026/02/18 | 4,510,520 | 7.21% (+4.00%) |
| 2026/02/17 | 1,998,711 | 3.21% (-0.25%) |
| 2026/02/16 | 2,163,665 | 3.46% (-0.12%) |
| 2026/02/13 | 2,234,779 | 3.58% (0.00%) |
| 2026/02/12 | 2,234,779 | 3.58% (+0.12%) |
| 2026/02/10 | 2,269,977 | 3.62% (-0.92%) |
| 2026/02/09 | 2,853,499 | 4.54% (-0.36%) |
| 2026/02/06 | 3,082,099 | 4.90% (+0.23%) |
| 2026/02/05 | 2,936,934 | 4.67% (-0.41%) |
| 2026/02/04 | 3,194,704 | 5.08% (+0.16%) |
| 2026/02/03 | 3,076,255 | 4.92% (-0.22%) |
| 2026/02/02 | 3,181,800 | 5.14% (+0.07%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全568件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| モルガン・スタンレーMUFG証券 | 4/6 | 631,427 | 0.87% (-0.03%) |
| Nomura | 4/2 | 1,615,921 | 2.24% (-0.14%) |
| GOLDMAN SACHS | 4/2 | 914,804 | 1.27% (-0.05%) |
| UBS | 4/2 | 433,600 | 0.60% (+0.01%) |
| Nomura | 4/1 | 1,715,098 | 2.38% (-0.11%) |
| GOLDMAN SACHS | 4/1 | 949,204 | 1.32% (+0.08%) |
| UBS | 4/1 | 424,900 | 0.59% (-0.01%) |
| GOLDMAN SACHS | 3/31 | 894,304 | 1.24% (+0.09%) |
| Macquarie Bank | 3/31 | 0 | 0.00% (-0.79%) |
| Nomura | 3/30 | 1,791,194 | 2.49% (-0.04%) |
| GOLDMAN SACHS | 3/30 | 830,604 | 1.15% (-0.14%) |
| UBS | 3/30 | 431,700 | 0.60% (+0.01%) |
| Nomura | 3/27 | 1,821,328 | 2.53% (-0.12%) |
| GOLDMAN SACHS | 3/27 | 932,604 | 1.29% (-0.20%) |
| Citigroup Global Markets | 3/27 | 357,400 | 0.49% (-0.20%) |
| モルガン・スタンレーMUFG証券 | 3/26 | 652,527 | 0.90% (+0.04%) |
| Nomura | 3/25 | 1,910,176 | 2.65% (-0.41%) |
| GOLDMAN SACHS | 3/25 | 1,074,204 | 1.49% (-0.09%) |
| モルガン・スタンレーMUFG証券 | 3/25 | 622,027 | 0.86% (-0.04%) |
| Citigroup Global Markets | 3/25 | 498,200 | 0.69% (-0.05%) |
| UBS | 3/25 | 424,600 | 0.59% (-0.04%) |
| Nomura | 3/24 | 2,199,642 | 3.06% (-0.21%) |
| Barclays Capital Securities | 3/24 | 335,304 | 0.46% (-0.28%) |
| Nomura | 3/23 | 2,354,729 | 3.27% (-0.18%) |
| JPM Securities Japan Co | 3/23 | 845,751 | 1.17% (-0.05%) |
| モルガン・スタンレーMUFG証券 | 3/23 | 652,627 | 0.90% (-0.11%) |
| Barclays Capital Securities | 3/23 | 535,304 | 0.74% (-0.41%) |
| Nomura | 3/19 | 2,482,294 | 3.45% (-0.46%) |
| GOLDMAN SACHS | 3/19 | 1,142,304 | 1.58% (-0.07%) |
| JPM Securities Japan Co | 3/19 | 879,451 | 1.22% (-0.13%) |